Artemisinin resistance phenotypes and K13 inheritance in a cross and model.

Proc Natl Acad Sci U S A 2018 12 19;115(49):12513-12518. Epub 2018 Nov 19.

Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;

Concerns about malaria parasite resistance to treatment with artemisinin drugs (ARTs) have grown with findings of prolonged parasite clearance s (>5 h) and their association with mutations in Kelch-propeller protein K13. Here, we describe a laboratory cross of K13 C580Y mutant with C580 wild-type parasites to investigate ART response phenotypes in vitro and in vivo. After genotyping >400 isolated progeny, we evaluated 20 recombinants in vitro: IC measurements of dihydroartemisinin were at similar low nanomolar levels for C580Y- and C580-type progeny (mean ratio, 1.00; 95% CI, 0.62-1.61), whereas, in a ring-stage survival assay, the C580Y-type progeny had 19.6-fold (95% CI, 9.76-39.2) higher average counts. In splenectomized monkeys treated with three daily doses of i.v. artesunate, calculations by three different methods yielded mean differences of 0.01 h (95% CI, -3.66 to 3.67), 0.80 h (95% CI, -0.92 to 2.53), and 2.07 h (95% CI, 0.77-3.36) between C580Y and C580 infections. Incidences of recrudescence were 57% in C580Y (4 of 7) versus 70% in C580 (7 of 10) infections (-13% difference; 95% CI, -58% to 35%). Allelic substitution of C580 in a C580Y-containing progeny clone (76H10) yielded a transformant (76H10) that, in an infected monkey, recrudesced regularly 13 times over 500 d. Frequent recrudescences of ART-treated infections occur with or without K13 mutations and emphasize the need for improved partner drugs to effectively eliminate the parasites that persist through the ART component of combination therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1813386115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298093PMC
December 2018
41 Reads
9.809 Impact Factor

Publication Analysis

Top Keywords

c580 infections
8
95%
6
yielded differences
4
differences 001
4
001 95%
4
95% -366
4
methods yielded
4
three methods
4
doses artesunate
4
artesunate calculations
4
calculations three
4
-366 367
4
080 95%
4
95% 077-336
4
077-336 c580y
4
c580y c580
4
infections incidences
4
207 95%
4
253 207
4
daily doses
4

Altmetric Statistics

Similar Publications